Advanced search
Publication Cover
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 35, 2022 - Issue 5
Submit an article Journal homepage
48
Views
0
CrossRef citations to date
0
Altmetric
Case Studies

Extranodal natural killer/T-cell lymphoma nasal type

Benjamin S. DainesDepartment of Otolaryngology–Head and Neck Surgery, Texas Tech University Health Sciences Center, Lubbock, TexasCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-9670-2423
, BSORCID Icon,
Rahul M. VarmanDepartment of Otolaryngology–Head and Neck Surgery, Texas Tech University Health Sciences Center, Lubbock, Texas
, MD &
Tam Q. NguyenDepartment of Otolaryngology–Head and Neck Surgery, Texas Tech University Health Sciences Center, Lubbock, Texas
, MD
Pages 672-674 | Received 14 Mar 2022, Accepted 25 Apr 2022, Published online: 16 May 2022

  • Neves MC, Lessa MM, Voegels RL, Butugan O. Primary non-Hodgkin’s lymphoma of the frontal sinus: case report and review of the literature. Ear Nose Throat J. 2005;84(1):47–51.
  • Rodrigo JP, Suarez C, Rinaldo A, et al. Idiopathic midline destructive disease: fact or fiction. Oral Oncol. 2005;41(4):340–348. doi:10.1016/j.oraloncology.2004.10.007.
  • Sheahan P, Donnelly M, O'Reilly S, Murphy M. T/NK cell non-Hodgkin's lymphoma of the sinonasal tract. J Laryngol Otol. 2001;115(12):1032–1035. doi:10.1258/0022215011909710.
  • Cai Q, Cai J, Fang Y, Young KH. Epstein-Barr virus-positive natural killer/T-cell lymphoma. Front Oncol. 2019;9:386. doi:10.3389/fonc.2019.00386.
  • Tse E, Kwong YL. How I treat NK/T-cell lymphomas. Blood. 2013;121(25):4997–5005. doi:10.1182/blood-2013-01-453233.
  • van Doesum JA, Nijland M, Brink M, Huls GA, van Meerten T. A West-European cohort of patients with NK/T-cell lymphoma, a population-based analysis. HemaSphere. 2020;5:e523.
  • Metgud RS, Doshi JJ, Gaurkhede S, Dongre R, Karle R. Extranodal NK/T-cell lymphoma, nasal type (angiocentric T-cell lymphoma): a review about the terminology. J Oral Maxillofac Pathol. 2011;15(1):96–100. doi:10.4103/0973-029X.80016.
  • Kommalapati A, Tella SH, Ganti AK, Armitage JO. Natural killer/T-cell neoplasms: analysis of incidence, patient characteristics, and survival outcomes in the United States. Clin Lymphoma Myeloma Leuk. 2018;18(7):475–479. doi:10.1016/j.clml.2018.04.009.
  • Allen PB, Lechowicz MJ. Management of NK/T-cell lymphoma, nasal type. J Oncol Pract. 2019;15(10):513–520. doi:10.1200/JOP.18.00719.
  • Kim SJ, Yoon DH, Jaccard A, et al. A prognostic index for natural killer cell lymphoma after non–anthracycline-based treatment: a multicentre, retrospective analysis. Lancet Oncol. 2016;17(3):389–400. doi:10.1016/S1470-2045(15)00533-1.
  • Ratech H, Burke JS, Blayney DW, Sheibani K, Rappaport H. A clinicopathologic study of malignant lymphomas of the nose, paranasal sinuses and hard palate including cases of lethal midline granuloma. Cancer. 1989;64(12):2525–2531. doi:10.1002/1097-0142(19891215)64:12<2525::AID-CNCR2820641220>3.0.CO;2-3.
  • Califano L, Zupi A, Maremonti P, De Rosa G. Sinonasal lymphoma presenting as a lethal midline granuloma: case report. J Oral Maxillofac Surg. 1998;56(5):667–671. doi:10.1016/s0278-2391(98)90471-2.
  • Montone KT. Differential diagnosis of necrotizing sinonasal lesions. Arch Pathol Lab Med. 2015;139(12):1508–1514. doi:10.5858/arpa.2015-0165-RA.
  • Tse E, Kwong YL. The diagnosis and management of NK/T-cell lymphomas. J Hematol Oncol. 2017;10(1):85. doi:10.1186/s13045-017-0452-9.
  • Fei Q, Tian XK, Wu J, et al. Prognostic significance of Epstein-Barr virus DNA in NK/T-cell lymphoma: a meta-analysis. Onco Targets Ther. 2018;11:997–1004. doi:10.2147/OTT.S153942.
  • Sands NB, Tewfik MA, Hwang SY, Desrosiers M. Extranodal T-cell lymphoma of the sinonasal tract presenting as severe rhinitis: case series. J Otolaryngol Head Neck Surg. 2008;37(4):528–533.
  • Jiang M, Zhang H, Jiang Y, et al. Phase 2 trial of “sandwich” L-asparaginase, vincristine, and prednisone chemotherapy with radiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer/T-cell lymphoma. Cancer. 2012;118(13):3294–3301. doi:10.1002/cncr.26629.
  • Kwong YL, Chan TSY, Tan D, et al. PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing l-asparaginase. Blood. 2017;129(17):2437–2442. doi:10.1182/blood-2016-12-756841.
  • Zou H, Pan KH, Wu L, Pan HY, Ding YH, Zheng MH. Nasal NK/T cell lymphoma presents with long-term nasal blockage and fever: a rare case report and literature review. Oncotarget. 2016;7(8):9613–9617. doi:10.18632/oncotarget.7386.
  • Zhang F, Duan X, Liu K. A case report of an extranodal NK/T-cell lymphoma nasal type, occurring primarily in eyes with masquerade syndrome. Medicine (Baltimore). 2019;98(11):e14836. doi:10.1097/MD.0000000000014836.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.